Plerixafor and G-CSF for autologous stem cell mobilization in patients with NHL, Hodgkin’s lymphoma and multiple myeloma: results from the expanded access programPaul Shaughnessy, Peter A. McSweeney, Michael J. Dugan et al.|Bone Marrow Transplantation|2012Cited by 35
Phase 1/2 study of intratumoral G100 (TLR4 agonist) with or without pembrolizumab in follicular lymphomaAhmad Halwani, Christopher R. Flowers, Carlos Panizo et al.|Leukemia & lymphoma/Leukemia and lymphoma|2021Cited by 20
Long Term Follow-up of a Phase 2 Study Examining Intratumoral G100 Alone and in Combination with Pembrolizumab in Patients with Follicular LymphomaChristopher R. Flowers, Ahmad Halwani, Carlos Panizo et al.|Blood|2018Cited by 7
Intratumoral G100 to induce systemic immune responses and abscopal tumor regression in patients with follicular lymphoma.Christopher R. Flowers, Ahmad Halwani, Iris Isufi et al.|Journal of Clinical Oncology|2017Cited by 2
Prolonged disease‐free survival and overall survival with CVP alternating with fludarabine in advanced follicular lymphomaWeiyun Z. Ai, Ronald Levy, Holbrook E. Kohrt et al.|American Journal of Hematology|2011Cited by 1